336.1Defining long-term functional recovery in face transplantation
Bruce Gelb (US)
Vascularized composite allotransplantation: Expanding frontiers in function, immunity, and clinical translation
Chairs
Patrik Lassus (FI)
· Peter J. Friend (GB)
Presentations
Mini-Oral Presentation
336.23-year longitudinal outcomes after the world’s first human whole eye transplant
Bruce Gelb (US)
336.3Human limb preservation using oxygenated machine perfusion with hemoglobin-based oxygen carriers modulates hypoxia and immune injury pathways
Varun Kopparthy (US)
336.4Vascular Composite Allograft Transplantation – A Single Center Experience From India
Shruti Tapiawala (IN)
336.5Emerging divides in attitudes towards uterus transplantation among health professionals in Australia and New Zealand
Hayley Mallinder (AU)
336.6Psychological and emotional profiles of Australian uterine transplant potential recipients: a comparison with international trials
Tamika Baker (AU)
336.7A decade of structural inequity in U.S. vascularized composite allotransplantation - A National OPTN Registry Analysis (1998–2024)
Girish Mour (US)
336.8NASEM-Guided CONSORT Consensus Recommendations and Standards for Face and Hand Vascularized Composite Allotransplantation: Establishing a Multicenter Clinical Trial Framework
Vijay Gorantla (US)